The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media-Related Antibiotic Use Among Young Children in Tennessee, USA

被引:4
作者
Griffith, Hannah [1 ]
Wiese, Andrew D. [1 ]
Mitchel, Edward F., Jr. [1 ]
Grijalva, Carlos G. [1 ,2 ]
机构
[1] Vanderbilt Univ, Dept Hlth Policy, Med Ctr, Nashville, TN USA
[2] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 03期
基金
美国国家卫生研究院;
关键词
otitis media; antibiotic use; pneumococcal conjugate vaccines; HEALTH-CARE UTILIZATION; ANTIMICROBIAL RESISTANCE; CHILDHOOD IMMUNIZATION; PNEUMONIA; HOSPITALIZATIONS; ADMISSIONS; DIAGNOSIS;
D O I
10.1093/ofid/ofac019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.
引用
收藏
页数:4
相关论文
共 28 条
  • [1] Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis
    Chapman, Ruth
    Sutton, Kelly
    Dillon-Murphy, Desmond
    Patel, Shreeya
    Hilton, Betsy
    Farkouh, Ray
    Wasserman, Matt
    [J]. VACCINE, 2020, 38 (45) : 7138 - 7145
  • [2] Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis
    Costelloe, Ceire
    Metcalfe, Chris
    Lovering, Andrew
    Mant, David
    Hay, Alastair D.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 : 1120
  • [3] Effectiveness of the 7-and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media
    Dagan, Ron
    van der Beek, Bart Adriaan
    Ben-Shimol, Shalom
    Pilishvili, Tamara
    Givon-Lavi, Noga
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) : 650 - 658
  • [4] Long-term prognosis of acute otitis media in infancy: determinants of recurrent acute otitis media and persistent middle ear effusion
    Damoiseaux, RAMJ
    Rovers, MM
    Van Balen, FAM
    Hoes, AW
    de Melker, RA
    [J]. FAMILY PRACTICE, 2006, 23 (01) : 40 - 45
  • [5] Pneumococcal conjugate vaccines for preventing acute otitis media in children
    de Sevaux, Joline L. H.
    Venekamp, Roderick P.
    Lutje, Vittoria
    Hak, Eelko
    Schilder, Anne G. M.
    Sanders, Elisabeth A. M.
    Damoiseaux, Roger A. M. J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):
  • [6] The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions
    Edmondson-Jones, Mark
    Dibbern, Therese
    Hultberg, Marcus
    Anell, Bengt
    Medin, Emma
    Feng, Yang
    Talarico, Carla
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (02) : 517 - 526
  • [7] Griffin MR, 2014, MMWR-MORBID MORTAL W, V63, P995
  • [8] US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
    Griffin, Marie R.
    Zhu, Yuwei
    Moore, Matthew R.
    Whitney, Cynthia G.
    Grijalva, Carlos G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) : 155 - 163
  • [9] Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA
    Grijalva, Carlos G.
    Griffin, Marie R.
    [J]. EXPERT REVIEW OF VACCINES, 2008, 7 (01) : 83 - 95
  • [10] Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
    Grijalva, Carlos G.
    Nuorti, J. Pekka
    Arbogast, Patrick G.
    Martin, Stacey W.
    Edwards, Kathryn M.
    Griffin, Marie R.
    [J]. LANCET, 2007, 369 (9568) : 1179 - 1186